‘Looksmaxxing’ Trend Spawns $100M Gray Market Fueled By Bitcoin, Stablecoins: Chainalysis

A fast-growing gray market for peptides has become one of the newest high-volume markets for cryptocurrency, according to a report report released Thursday by Chainalysis, which processes more than $100 million annually, primarily through Bitcoin and stablecoin payments.

The blockchain data company found that crypto flows to peptide suppliers increased from approximately $12 million in the fourth quarter of 2025 to $32 million in the first quarter of 2026, an increase of 159%. The market is on track to process about $39 million in the second quarter, the company said.

“What started as a silent, underground community of biohackers using crypto to bypass traditional gatekeepers has since mutated into a financial juggernaut,” Chainalysis wrote. “First fueled by sudden political legitimacy and later by a viral internet subculture known as ‘looksmaxxing,’ the on-chain peptide ecosystem is experiencing a breakout.”

Looksmaxxing is a social media-driven trend that focuses on maximizing physical attractiveness through fitness, grooming, nutrition, supplements, cosmetic procedures and other appearance-enhancing interventions. Unlike biohacking, which is generally aimed at improving health, performance or longevity, looksmaxxing is mainly focused on appearance.

Peptides are short chains of amino acids used in medical and cosmetic treatments, including the active ingredients behind popular weight-loss medications such as Ozempic and Wegovy. While the availability and cost of these drugs have declined under President Donald Trump’s administration, demand for cheaper alternatives has fueled a growing network of foreign suppliers selling generic peptide products directly to consumers.

Unlike previous online black markets such as the Silk Road, Chainalysis says gray markets gained popularity during the rise of the Make America Healthy Again movement and growing interest in alternative healthcare approaches, but accelerated sharply in early 2026. The company estimates that the industry now processes tens of millions of dollars of cryptocurrency every quarter, pushing the annual run rate above $100 million.

Many vendors, the report said, are relying on Bitcoin and stablecoins as banks and payment processors restrict payments linked to unapproved pharmaceutical compounds, with many of the larger operators increasingly favoring stablecoins – which are typically pegged to the dollar and reduce exposure to price fluctuations in the crypto market.

“This preference for stability is especially pronounced at the wholesale level,” Chainalysis wrote. “Isolating suppliers with an average value of $1,000 or more per deposit shifts the asset mix sharply towards the majority of stablecoins – a potentially calculated move to isolate massive supply chain orders from the unpredictable price swings of the broader crypto market.”

In addition, the company identified several Chinese chemical manufacturers that it says were targeting peptide sales after previously supplying fentanyl and amphetamine precursors, including Shanghai Sigma Audley and Bigreat Technology.

“By turning to gray market peptides, these China-based suppliers are now selling coveted finished products directly to the end user,” the report said. “This direct-to-consumer model allows them to cut out the cartel middlemen, capture the full retail profit margin and dramatically increase their revenues while lowering their legal risk.”

Chainalysis did not immediately respond to a request for comment from Declutter.